Metabolic and apoptotic regulators

Metabolic and apoptotic regulators represent a broad functional class of proteins and signaling pathways that coordinate the interplay between cellular energy metabolism and the programmed cell death machinery (Green & Kroemer, 2009, Nature Reviews Molecular Cell Biology). These regulators include key molecular players such as the BCL-2 protein family, which governs mitochondrial outer membrane permeability, and the mTOR signaling complex, which integrates nutrient availability with cell growth and survival signals (Saxton & Sabatini, 2017, Cell). Under physiological conditions, these molecules ensure that cells maintain metabolic homeostasis or undergo orderly apoptosis if they become severely damaged or nutrient-deprived (Danial & Korsmeyer, 2004, Cell). In many diseases, particularly oncology, these regulators are frequently dysregulated; for example, cancer cells often overexpress anti-apoptotic proteins to evade death signals despite the high metabolic stress of the tumor microenvironment. Consequently, specific proteins within this category have become major therapeutic targets, leading to the development of drugs like Venetoclax (a BCL-2 inhibitor) and various mTOR inhibitors used in cancer and transplant medicine. However, because this term describes a functional group rather than a single molecular entity, it is considered a category of targets rather than a specific therapeutic target itself.

Other names

Metabolic and cell death regulatorsApoptosis and metabolism signaling proteinsRegulators of cellular energetics and survival

Drugs targeting specific members of this category typically act by inhibiting anti-apoptotic proteins to restore sensitivity to death signals or by modulating nutrient-sensing pathways to inhibit pathological cell growth and proliferation.